TY - JOUR
T1 - Renal Cell Carcinoma of Variant Histology
T2 - Biology and Therapies
AU - Msaouel, Pavlos
AU - Genovese, Giannicola
AU - Tannir, Nizar M.
N1 - Funding Information:
The authors would like to thank Dr Jeffrey Graham for providing the exact numbers of PRCC and CHRCC responders in the Graham and colleagues study used in our meta-analysis. 21 P. Msaouel is supported by the MD Anderson Khalifa Scholar Award , the Andrew Sabin Family Foundation Fellowship , a Translational Research Partnership Award (KC200096P1) by the United States Department of Defense, an Advanced Discovery Award by the Kidney Cancer Association , a Translational Research Award by the V Foundation, the MD Anderson Physician-Scientist Award, donations from the Renal Medullary Carcinoma Research Foundation in honor of Ryse Williams, as well as philanthropic donations by the Chris “CJ” Johnson Foundation, and by the family of Mike and Mary Allen. G. Genovese is supported by the NIH, United States R01CA258226 , the NIH R21 CA259799-01A1 and Translational Research Partnership Award ( KC200096P1 ) by the United States Department of Defense.
PY - 2023/10
Y1 - 2023/10
KW - Chromophobe renal cell carcinoma
KW - Collecting duct carcinoma
KW - MiTF translocation renal cell carcinoma
KW - Nonclear cell renal cell carcinoma
KW - Papillary renal cell carcinoma
KW - Renal medullary carcinoma
UR - http://www.scopus.com/inward/record.url?scp=85160289542&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85160289542&partnerID=8YFLogxK
U2 - 10.1016/j.hoc.2023.04.019
DO - 10.1016/j.hoc.2023.04.019
M3 - Review article
C2 - 37244822
AN - SCOPUS:85160289542
SN - 0889-8588
VL - 37
SP - 977
EP - 992
JO - Hematology/Oncology Clinics of North America
JF - Hematology/Oncology Clinics of North America
IS - 5
ER -